Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study
Kamen A Tsvetanov, Lennart R B Spindler, View ORCID ProfileEmmanuel A Stamatakis, Virginia FJ Newcombe, Victoria C Lupson, Doris A Chatfield, Anne E Manktelow, Joanne G Outtrim, Anne Elmer, Nathalie Kingston, John R Bradley, View ORCID ProfileEdward T Bullmore, View ORCID ProfileJames B Rowe, David K Menon, The Cambridge NeuroCOVID Group, The NIHR COVID-19 BioResource, The Cambridge NIHR Clinical Research Facility, The CITIID-NIHR BioResource COVID-19 Collaboration
doi: https://doi.org/10.1101/2022.02.01.22270235
Kamen A Tsvetanov
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
2Department of Psychology, University of Cambridge, Cambridge, UK
Lennart R B Spindler
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
Emmanuel A Stamatakis
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
4Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK
Virginia FJ Newcombe
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
4Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK
Victoria C Lupson
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
4Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK
Doris A Chatfield
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
Anne E Manktelow
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
Joanne G Outtrim
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
Anne Elmer
5Cambridge Clinical Research Centre, NIHR Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, UK
Nathalie Kingston
6NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK
7Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
John R Bradley
7Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
8Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
Edward T Bullmore
9Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
James B Rowe
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
10Medical Research Council Cognition and Brain Sciences Unit, Department of Psychiatry, Cambridge, UK
David K Menon
3Division of Anaesthesia, Department of Medicine, University Cambridge, Cambridge, UK
4Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK
5Cambridge Clinical Research Centre, NIHR Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplemental Information[supplements/270235_file03.pdf]
Posted February 02, 2022.
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study
Kamen A Tsvetanov, Lennart R B Spindler, Emmanuel A Stamatakis, Virginia FJ Newcombe, Victoria C Lupson, Doris A Chatfield, Anne E Manktelow, Joanne G Outtrim, Anne Elmer, Nathalie Kingston, John R Bradley, Edward T Bullmore, James B Rowe, David K Menon, The Cambridge NeuroCOVID Group, The NIHR COVID-19 BioResource, The Cambridge NIHR Clinical Research Facility, The CITIID-NIHR BioResource COVID-19 Collaboration
medRxiv 2022.02.01.22270235; doi: https://doi.org/10.1101/2022.02.01.22270235
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study
Kamen A Tsvetanov, Lennart R B Spindler, Emmanuel A Stamatakis, Virginia FJ Newcombe, Victoria C Lupson, Doris A Chatfield, Anne E Manktelow, Joanne G Outtrim, Anne Elmer, Nathalie Kingston, John R Bradley, Edward T Bullmore, James B Rowe, David K Menon, The Cambridge NeuroCOVID Group, The NIHR COVID-19 BioResource, The Cambridge NIHR Clinical Research Facility, The CITIID-NIHR BioResource COVID-19 Collaboration
medRxiv 2022.02.01.22270235; doi: https://doi.org/10.1101/2022.02.01.22270235
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2655)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12245)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2665)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)